Egypt vs Gabon: HIV/AIDS deaths averted by antiretroviral therapy
Egypt
2,035 deaths
in 2024
Gabon
2,398 deaths
in 2024
Egypt rank
56th
Gabon rank
53rd
HIV/AIDS deaths averted by antiretroviral therapy over time
- Egypt
- Gabon
How they compare
Gabon currently reports 2,398 deaths against 2,035 deaths in Egypt, a difference of 363 deaths.
That makes Gabon's figure about 1.2 times Egypt's.
Across all 35 years both countries report, Gabon has been ahead every year.
Egypt ranks 56th and Gabon ranks 53rd of 157 countries.
Gabon has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Egypt | Gabon | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 23.89 deaths | 658.44 deaths | 634.55 deaths | Gabon |
| 2010s | 346.74 deaths | 2,011 deaths | 1,665 deaths | Gabon |
| 2020s | 1,477 deaths | 2,106 deaths | 629.08 deaths | Gabon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Egypt or Gabon?
- Gabon, at 2,398 deaths against 2,035 deaths in Egypt as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Egypt and Gabon?
- 363 deaths, with Gabon ahead.
- How many years of comparable data are there for Egypt and Gabon?
- 35 years are reported by both, from 1990 to 2024.
- How do Egypt and Gabon rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Egypt ranks 56th and Gabon ranks 53rd of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.